An ambispective analysis of pathologically proven MTC presented in a tertiary care hospital in northwest India was performed after considering demography, clinical manifestation, RET mutation status, management, and outcome as denominators. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.